Hosted on MSN2d
Anti-TIGIT Shows Promise in Unresectable Liver CancerAddition of the anti-TIGIT monoclonal antibody tiragolumab to standard first-line treatment resulted in better response rates ...
Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback